Table of contents

Reviews

• H ₂ S-based therapies for ischaemic stroke: opportunities and challenges

  (4 July, 2019)

  Jia Jia, Jie Li, Jian Cheng
• CCM3 and cerebral cavernous malformation disease (2 March, 2019)

  Kang Wang, Huanjiao Jenny Zhou, Min Wang
• Microglial activation after ischaemic stroke (10 May, 2019)

  Shengxiang Zhang
• MRI and glymphatic system (5 April, 2019)

  Quan Jiang
• Basement membrane and blood–brain barrier (5 December, 2018)

  Lingling Xu, Abhijit Nirwane, Yao Yao
• Targeting NAMPT as a therapeutic strategy against stroke (5 April, 2019)

  Shu-Na Wang, Chao-Yu Miao
• Role of the glymphatic system in ageing and diabetes mellitus impaired cognitive function (10 May, 2019)

  Li Zhang, Michael Chopp, Quan Jiang, Zhenggang Zhang
• Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage (13 January, 2019)

  Jieru Wan, Honglei Ren, Jian Wang
• Non-coding RNA and neuroinflammation: implications for the therapy of stroke (2 March, 2019)

  Ling Shen, Ying Bai, Bing Han, Honghong Yao
• Neuroimaging studies on cognitive impairment due to cerebral small vessel disease (5 April, 2019)

  Jing Du, Qun Xu
• High-resolution MRI of intracranial large artery diseases: how to use it in clinical practice? (20 June, 2019)

  Weihai Xu
• Cerebral microvascular dysfunction and neurodegeneration in dementia (24 June, 2019)

  Feng Han